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Abstract.  IMR-32 human neuroblastoma cells are un- 
able to release [3H]dopamine  in response to secreta- 
gogues. However,  they express a normal complement 
of membrane receptors and ion channels which are 
efficiently coupled to second messenger production. In 
the present study we took advantage of the ability of 
this cell line to differentiate in vitro in the presence of 
either dibutyrryl-cAMP or 5-bromodeoxyuridine, to 
analyze any developmentally regulated changes in its 
secretory properties.  Uptake,  storage, and release of 
[3H]dopamine  were studied biochemically and by auto- 
radiography. The calcium ionophore ionomycin, phor- 
bol  12-myristate 13-acetate  and the presynaptic acting 
neurotoxin a-latrotoxin were used in both control and 
differentiated cells as secretagogue agents.  The pres- 
ence of secretory organelles was investigated  by elec- 
tron microscopy; the expression of secretory organelle 
markers, such as chromogranin/secretogranin proteins 
(secretory proteins) and synaptophysin (membrane pro- 
tein), was detected by Western  blotting and im- 
munofluorescence. The results obtained indicate that 
IMR-32 cells acquire regulated secretory properties af- 
ter in vitro drug-induced differentiation: (a) they as- 
semble "de novo" secretory organelles, as revealed by 
electron microscopy and detection of secretory or- 
ganelle markers, and (b) they are able to store 
[3H]dopamine  and to release the neurotransmitter in 
response to secretagogue stimuli. Furthermore, 
secretagogue sensitivity was found to be different, de- 
pending on the differentiating agent. In fact, 
dibutyrryl-cAMP treated cells release [3H]dopamine  in 
response to ot-latrotoxin,  but not in response to 
ionomycin, whereas 5-bromodeoxyuridine treated cells 
release the neurotransmitter in response to both 
secretagogues. All together these results suggest that 
IMR-32 cells represent an adequate model for studying 
the development of the secretory apparatus in cultured 
human neurons. 
T 
HE coupling  between  receptor  activation  and  trans- 
mitter re!ease, also referred to as "stimulus-secretion 
coupling,  is a fundamental cellular process which is 
still poorly defined at the molecular level especially in neu- 
rons (Augustine et al.,  1987; Bell,  1988; Burgoyne,  1987; 
Gomperts,  1986; Kretsinger and Creutz,  1986). The study 
of  this process would be made much easier if it were possible 
to dissect the different events that occur between the stimulus 
and the secretory response, i.e., receptor activation, second 
messenger production,  neurotransmitter  synthesis and stor- 
age,  and vesicle  fusion.  Human neuroblastoma  cell  lines, 
which  have several  characteristics  of neuronal  cells  and 
where the expression of neuron-specific enzymes, proteins, 
and organelles  can be modulated  according  to the culture 
conditions (Gotti et al., 1987; Gupta et al., 1985; Prasad et 
al., 1973; Reynolds and Perez-Polo, 1981; Ross et al., 1980; 
Rupniak et al.,  1984; Sidell,  1982; Spinelli et al.,  1982) 
could represent a useful cell model to study the expression 
of these properties.  We have previously shown that IMR-32 
cells,  established  in vitro by Tumilowicz et al.  (1970), are 
able  to  take  up  the  neurotransmitter  [3H]dopamine  (3H- 
DA)'  by a specific,  high affinity, uptake system, but are 
not able to release it in response to classical secretagogue 
agents (Clementi et al.,  1986). 
We have also shown that this "defect" might be at the level 
of some steps of  the regulated secretory machinery itself  and 
not at the level of receptor activation or second messenger 
modulation, since in these cells membrane receptors and ion 
channels are present and functioning (Clementi et al., 1986; 
Gotti et al., 1986; Sher et al., 1988a), and different secreta- 
gogues are able to modulate intracellular free calcium con- 
centration  ([CaZ+],) levels (Sher et al.,  1988b). 
IMR-32 cells also have the interesting property of  differen- 
tiating in vitro  in response  to pharmacological  agents, to- 
I. Abbreviations  used in this paper: ot-LTx, ~-latrotoxin:  Bt2cAMP, N6-D  2- 
dibutyrryl-cyclic  adenosine 3'5' monophosphate; BrdU, 5'-bromo-2' deoxy- 
uridine;  [Ca2+li,  intracellular-free  calcium  concentration; Cg/Sg,  chro- 
mogranin/secretogranin;  3H-DA, 3H-dopamine; KRH,  Krebs-Ringer-Hepes 
medium; TPA, phorbol  12-myristate  13-acetate. 
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ated not only morphologically, but also biochemically or 
functionally (Gotti et al.,  1987; Gupta et al.,  1985;  Prasad 
et al.,  1973;  Reynolds and Perez-Polo,  1981; Thompson et 
al.,  1982). 
In the present study we investigated whether the ability 
to release 3H-DA could be acquired by IMR-32 cells after 
exposure to differentiating  agents,  such as N6-(Y-dibutyrryl - 
cyclic adenosine 3'5' monophosphate (Bt2cAMP) or 5'-bro- 
mo-2' deoxyuridine (BrdU). We first studied neurotransmit- 
ter storage in control and differentiated cells by analyzing 
their ability to take up and store 3H-DA in secretory organ- 
elles  that  were  visualized  by  electron  microscopy  and 
characterized by the presence of chromaffin granule antigens 
and synaptophysin, an integral membrane protein of synaptic 
vesicles.  Neurotransmitter release was investigated by the 
use of three secretagogue agents,  which activate different 
pathways: (a)  ionomycin (Ca2÷-dependent release);  (b) phor- 
bol 12-myristate  13-acetate (TPA) (Ca2+-independent release 
possibly related to protein kinase C activation plus synergy 
with Ca:+-dependent release); and (c) c~-latrotoxin (c~-LTx) 
from black widow spider venom (Ca:÷-dependent plus Ca  :÷- 
independent release  mediated by unknown mechanisms). 
IMR-32 cells were found to be able to assemble secretory or- 
ganelles, to store in them 3H-DA, and to release the neu- 
rotransmitter in response to secretagogue agents, only after 
differentiation. Furthermore, interesting differences in stim- 
ulus-secretion coupling were detected in cells differentiated 
with different drugs. 
Materials and Methods 
Cell Culture 
The IMR-32 cell line (obtained from the American Type Culture Collec- 
tion, Rockville, MD) was grown as previously described (Clementi et al., 
1986)  in  MEM containing Earle's  salts,  10%  heat-inactivated FCS,  100 
IU/ml penicillin, and 100 #g/ml streptomycin. The experiments were per- 
formed on cells between passage 70 and 85.  Cells were usually plated at 
a concentration of 5  x  103/cm 2 and used 12-13 d later when they reached 
confluency. 
To induce differentiation, the cells were treated after the first medium 
change (2 d after plating), with 1 mM Bt2cAMP or 2.5 p.M BrdU dissolved 
in culture medium. Drugs were added every 3 d  at each medium change 
and the cells used 12 d  later, unless otherwise indicated. 
Cells to be used for immunolocalization studies were grown on gelatin- 
coated round glass coverslips (24 mm in diameter) inserted in 35-mm Petri 
dishes. 
3H-DA Uptake, Storage, and Release 
Uptake experiments were performed as described (Clementi et al.,  1986) 
with slight modifications. Cells were gently detached from the Petri dishes, 
transferred to siliconized tubes, and centrifuged at 150 g for 5 min. Pelletted 
cells were resuspended (3  x  107 cells/ml) in a  Krebs-Ringer-Hepes me- 
dium (KRH) containing 125 mM NaC1, 5 mM KC1,  1.2 mM KHEPO4 and 
MgSO4, 2  mM CaC12,  25 mM Hepes/NaOH buffer (pH 7.4), and 6  mM 
glucose. The medium also contained 0.1 mg/ml each of ascorbate and the 
monoamine oxidase inhibitor pargyline plus the desired amount of 3H-DA 
(from 0.1  to 5.0 ~M).  Sister cells were incubated in the same mixture to 
which 2  ~M desmethytimipramine was added, which is known to inhibit 
the high affinity amine uptake system in catecholaminergic neurons and in 
IMR-32 cells (Richards and Sadee,  1986).  Uptake experiments were per- 
formed for 30 min at 37°C in an oscillating bath (50 rpm). 
For release experiments, cells were incubated in the above medium for 
60 min at 37°C. After incubation the cells were pelletted by centrifugation 
for 5 min at 150g and resuspended in KRH containing 2 ttM desmethylimi- 
pramine and the various secretagogues to be tested (10 #M reserpine, 1/~M 
ionomycin, 160 nM TPA, 2 nM ct-LTx).  Since some drugs were dissolved 
in dimethylsulfoxide, control cells received the same amount of solvent 
alone. The cells were then returned to 37°C for 8 min unless otherwise indi- 
cated, centrifuged, washed twice with ice-cold KRH buffer, and finally the 
pellets were counted to determine the amount of 3H-DA remaining in the 
cells. Samples, dissolved in 200 td of NaOH and then in 10 ml of Atomtight, 
were counted in a beta-counter (model L57500; Beckman Instruments Inc., 
Palo Alto, CA) with an efficiency of ~40%. 
Visualization of~H-DA by Autoradiography 
The cultures were incubated for  1 h at 36°C with 0.5 ~tM 3H-DA in Dul- 
becco's PBS (D-PBS).  Incubation was stopped by means of three D-PBS 
washes. Cells were then fixed for 1 b at room temperature in 1.5%  glutar- 
aldehyde in PBS, extensively washed in PBS, air dried, and coated with ll- 
ford emulsion K5 diluted  1:1  with water.  They were exposed for  1 wk in 
the dark before being developed with DI9 developer (Eastman Kodak Co., 
Rochester, NY). 
Electron Microscopy 
Cells were fixed with 2% glutaraldehyde in PBS for  1 h, postfixed in  1% 
OsO4 for  I  h,  dehydrated in acetone,  and embedded in Epon.  Sections 
were observed using a  Philips CMI0 electron microscope. 
Measurements of  [Ca2+]i with Quin-2 
These experiments were performed as described by Sher et al.  (1988b). 
Briefly,  the cells were mechanically detached from the dishes, centrifuged 
for 5 min at  150 g, and resuspended at a concentration of l07 cells/ml in 
MEM containing 3 % FCS and 50 tzM quin2 acetoxymethylester (quin2- 
AM) in dimethylsulfoxide (0.5%  of final volume). After 20 min at 37°C, 
the cells were further diluted with the same medium and left at 37°C for 
additional 60 min. Before the fluorescence assay, the cells were pelletted 
in a microfuge and resuspended at a concentration of 106 cells/ml in 1.5 ml 
of KRH. 
All the assays were carried out in a spectrofluorimeter (model LS-5; Per- 
kin Elmer Corp., Eden Prairie, MN) (excitation: 339  5:5 nm; emission: 
492  +  10 nm), using a cuvette positioned in a thermostatically controlled 
(36 _+  I°C) ceil holder equipped with magnetic stirring. Calibration of the 
fluorescence signal was performed  as  described  by  Tsien et  al.  (1982). 
Whenever necessary, the data were corrected for changes in cell autofluores- 
cence. 
Detection of Secretory Organelle Markers 
Nondifferentiated and BrdU-differentiated pelletted cells were homogenized 
in 0.25 M sucrose plus 0.5 mM PMSF and centrifuged at 600 g for 10 min. 
The presence of secretory proteins, mainly chromogranins/secretogranins 
(Cgs/Sgs) (Eiden et al.,  1987),  in the supernatants was detected by West- 
ern blotting (Burnette,  1981). Proteins were separated by two-dimensional 
PAGE, as described by Zanini and Rosa (1981) on a  Mini Protean II cell 
(Bio-Rad Laboratories, Richmond, CA), and were transferred to nitrocellu- 
lose membranes at 300 mA for 5  h.  An antiserum raised in mice against 
human pheochromocytoma chromaffin granules,  which  recognized both 
CgA and CgB/Sgl (kindly given by Drs. A. Siccardi and M. Pelagi, Depart- 
ment of Biology, University of Milan), was used diluted 1:200. Horseradish 
peroxidase-conjugated anti-mouse IgGs were used diluted 1:1,000. The im- 
munoreaction was visualized by means of 3,3'-diaminobenzidine. 
To detect synaptophysin, proteins were separated by SDS-PAGE as de- 
scribed by Maizel (1971), in 10% polyacrylamide gel slabs. Immunoblotting 
was performed by using afffinity-purified  polyclonal anti-synaptophysin an- 
tibodies diluted 1:10 (kindly given by Dr. R. Jahn, Max-Planck-Institut fur 
Psychiatrie, Munchen, FRG), and the immunoreaction was visualized by 
means of 4-chloro-l-naphtol. 
Synaptophysin was quantitated by densitometric analysis of the immuno- 
blots in a  laser densitometer (UItroscan XL; LKB Instruments, Gaithers- 
burg, MD). 
Immunolocalization of  Secretory Organelle Markers 
For immunolocalization studies, a variation of the method described by Gei- 
ger and Singer (1979) was used. Control and differentiated IMR-32 cells, 
grown on gelatin-coated glass coverslips, were washed twice with D-PBS 
and fixed in the same buffer, containing I% paraformaldehyde, for 20 rain 
at room temperature. Cells were then washed with D-PBS plus 0.1%  BSA 
The Journal of Cell  Biology, Volume 108,  1989  2292 (3  x  5 min) and, at the second wash, a drop of glycine (1 M, pH 8) was  loo 
added to quench residual aldehyde activity. The cells were permeabilized 
by a 5-min incubation with 0.1% Triton in D-PBS, followed by three addi-  B0 
tional washes. Permeabilized cells were incubated for 1 h at room tempera- 
ture with either the polyclonal anti-chromaffin granule antiserum (diluted  60 
1:25) or the polycional anti-synaptophysin antibodies (diluted 1:10), or an 
anti-DA antiserum (diluted 1:400) and further washed three times for a total  ~0 
of 30 min. The cells were then incubated in the presence of a biotinylated 
secondary antibody for 30 min (diluted 1:100) and, after three additional  ~  20 
t3.  washes, incubated in the presence of Avidin Texas red (diluted 1:100) for 
15 min. The coverslips were mounted on a drop of Moviol on glass micro- 
scope slides and viewed in a  Zeiss Axiophot microscope equipped for  E 
epifluorescence. Pictures were taken with a Technical Pan 2415 film (East-  _c 
man Kodak Co.) developed with D19 developer.  E 
Materials 
MEM, FCS, and antibiotics were obtained from Flow Laboratories, Inc. 
(Ayrshire, Scotland).  Plastic Petri dishes were purchased from Corning 
Glass Works (Corning, NY) and BrdU, Bt2cAMP, gelatin, pargyline, des- 
methylimipramine, TPA, and 3,3' diaminobenzidine were purchased from 
Sigma Chemical Co. (St. Louis, MO). 3H-DA (specific activity 5-15 Ci/ 
mmol) was from Amersham as well as the biotinylated anti-mouse IgG anti- 
bodies and Avidin Texas red. Atomlight was from New England Nuclear 
(Boston,  MA) and Moviol from Calbiochem-Behring Corp.  (San Diego, 
CA).  Rabbit anti-DA antiserum was obtained from Sera-Lab (Crawley 
Down,  UK).  Horseradish  peroxidase-conjugated goat  anti-mouse  lgG 
were from Organon Teknika-Cappel (Malvern, PA). lonomycin and quin2- 
acetoxymethylester were obtained from Calbiochem-Behring Corp., and 
4-chloro-l-naphtol was purchased from Bio-Rad Laboratories. e-LTx, puri- 
fied as described (Frontali et al., 1976), was a kind gift of Dr. L. Madeddu 
and L. Rosenthal from our institute. 
All other reagents were of reagent grade and were purchased from E. 
Merck (Darmstadt, FRG). 
Results 
Uptake and Storage of~H-DA 
We have previously shown that neurotransmitter synthesis 
occurs both in control and differentiated cells (Gotti et al., 
1987). We checked if both undifferentiated and differentiated 
IMR-32 cells were able to take up 3H-DA in a specific, high- 
affinity and saturable fashion. Both control and differentiated 
cells take up 3H-DA,  but BrdU-differentiated cells take up 
much more labeled neurotransmitter (Vm~: 78.2  fmol/min 
per mg of protein) than Bt2cAMP-differentiated ceils (Vmax: 
30.2 fmol/min per mg of protein) or control cells (Fig. 1 A). 
However, no significant difference was found in the affinity 
for 3H-DA of the uptake system in the different phenotypes 
(Fig.  1 B). We thus tested if there could be differences be- 
tween control and differentiated cells in the ability to assem- 
ble secretory organelles and store 3H-DA taken up from the 
medium. To test this hypothesis, storage of dopamine was 
evaluated autoradiographically, biochemically, and by im- 
munofluorescence. Control and differentiated cells were in- 
cubated for  1 h  with 3H-DA  (0.5  /~M),  in the absence of 
pargyline. Under such conditions only 3H-DA stored in se- 
cretory granules could be viewed since, unlike cytoplasmic 
3H-DA,  it is protected from degradation operated by mono- 
amine oxidases. We found that very few control cells were 
labeled,  probably  only  the  spontaneously  differentiating 
cells (Fig. 2 a). On the contrary, a greater proportion of cells 
was labeled in both BhcAMP- and BrdU-differentiated cul- 
tures. The intracellular labeling was not uniform, suggesting 
that 3H-DA was concentrated in discrete subcellular struc- 
tures. In Bt2cAMP-treated cells, labeling was concentrated 
at the periphery of the cell body, in particular in the short 
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Figure I. Kinetics of uptake of DA by IMR-32 cells. (A) Velocity of 
initial uptake of DA expressed ai a function of total DA concentra- 
tion in the external medium. Each data point represents the average 
of triplicate determinations. Final concentration of 3H-DA, 0.1  × 
10  -6 M. (B) Hofstee plot (Hofstee, 1959) of data in A. Line was 
fitted by least-squares analysis, e, control cells; o, Bt2cAMP-treat- 
ed cells; ,x BrdU-treated cells. 
neurites (Fig.  2 b).  In BrdU-treated cells,  which exhibit a 
more differentiated phenotype, the labeling was concentrated 
along neurites and in varicosities (Fig. 2 c). The same type 
of compartmentalization could also be observed in BrdU- 
differentiated cells by immunofluorescence using  anti-DA 
antiserum (Fig. 2 d), suggesting that both endogenous and 
exogenous DA was  stored in similar structure. 
Further indication of the subcellular localization of 3H- 
DA could be obtained by studying the ability of reserpine (10 
/zM)  to induce depletion of stored 3H-DA by both control 
and differentiated cells. These experiments were performed 
in the presence of the monoamine oxidase inhibitor pargy- 
line. Under such conditions, the amount of 3H-DA released 
("reserpine-sensitive") is  an  indirect  measurement  of the 
amount of transmitter actually stored in granules (Langhey 
and Kirshner,  1987). As shown in Table I, in control IMR- 
32  cells the  amount of 3H-DA  stored  in granules  is  very 
low (•7%),  whereas it represents a  greater proportion in 
Bt2cAMP- (,,o15  %) and BrdU- (~25 %) differentiated ceils. 
Electron Microscopy 
A striking difference was found between control and differ- 
entiated IMR-32  cells at the ultrastructural level. Control 
cells had none or very few secretory vesicles in the cyto- 
plasm or in the short neurites (Fig. 3 a), whereas in both 
Bt2cAMP-  (Fig.  3  b)  and  5BrdU- (Fig.  3  c) treated cells 
many secretory organelles were present. 
The great majority of these secretory organelles had a 
"dense core"; they were irregular in shape and highly hetero- 
geneous in dimension. Few "clear" small vesicles, possibly 
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Percent increase of release 
Control  Bt,cAMP  BrdU 
Reserpine  7  +  2  15  ___ 2  23  ___ 3 
(1  ×  10  -5 M) 
DMSO (1%)  2 +  1  3  +  1.5  2  +  1 
The cells were incubated for 2.5 h at 37°C with the drug or with the same 
amount of DMSO  alone. Values represent the average ± SEM of three differ- 
ent experiments. 
related to synaptic vesicles were found, scattered throughout 
the cytoplasm and in the neurites. 
Detection of Secretory Organelle Proteins 
Secretory granule proteins were detected after separation by 
two-dimensional PAGE from both control and BrdU-differ- 
entiated cell homogenates, and immunoblotting with an anti- 
human chromaflin granule antiserum.  As shown in Fig. 4, 
some proteins were specifically recognized by this antiserum 
only in differentiated cells; in particular,  two acidic compo- 
nents corresponding to CgA and CgB/Sgl were clearly de- 
tectable in BrdU-differentiated cells (Fig. 4 b) and not in con- 
trol cells  (a). 
Immunofluorescence experiments with the anti-chromaf- 
fin granule antiserum revealed that in control IMR-32 cells 
only low levels of granule proteins were detectable in a few 
punctate structures mainly at the periphery of the cell (Fig. 
5, a  and b). On the contrary, a very strong dotted signal was 
found in BrdU-differentiated cells at the level of  the Golgi ap- 
paratus,  near the plasma membrane, along neurites and in- 
side varicosities and "terminals" (Fig. 5, c-e). Similar results 
were obtained in Bt2cAMP-treated cells  (not shown). 
Moreover we followed the regulation of expression  of a 
marker of secretory vesicles membranes by using an attinity- 
purified antibody directed against synaptophysin. This Ca  2÷- 
binding transmembrane glycoprotein is probably present on 
different types of secretory organelles (Navone et al.,  1986; 
Lowe et al.,  1988; Obendorf et al.,  1988),  but it seems to 
be enriched in small, nonpeptidergic, synaptic vesicles (Na- 
vone et al.,  1986;  Obendorf et al.,  1988). 
Differentiated  IMR-32 cells  express  more synaptophysin 
than control cells as revealed by immunoblotting. Densitom- 
eter scans of the immunoblots indicate a '~100 % increase in 
the amount of synaptophysin doublet in differentiated  cells 
compared with control cells  (Fig.  6  a). 
In  immunofluorescence  studies  (Fig.  6,  b,  c,  and  d),  a 
Figure 2.  Autoradiography  of 3H-DA  and  immunofluorescence 
with anti-DA antiserum.  Control (a) Bt2cAMP- (b) and BrdU- (c) 
treated IMR-32 cells were loaded with 3H-DA (0.5 #M, 60 min at 
37°C) and processed for autoradiography.  Very few cells are labeled 
in control cultures  (a), while both types of differentiated  cultures 
accumulate a great amount of neurotransmitter.  Note the particular 
compartmentalization  of labeled  structures  in the short neurites  in 
Bt2cAMP-treated cells  (b) and along the long processes of BrdU- 
treated cells (c). In d the immunofluorescence pattern obtained with 
the anti-DA antiserum in BrdU-treated cells is shown.  A punctate 
labeling  in the cytoplasm and along neurites  is clearly noticeable. 
Bars,  50 #m. 
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antiserum. Proteins from control (a) and BrdU-differentiated (b) 
IMR-32 cell homogenates  were separated by two-dimensional PAGE. 
blotted, and immunostained as described in Materials and Methods. 
Only differentiated IMR-32 cells express a significant  amount of  the 
two granule-specific proteins CgA (A) and CgB/Sgl (B), as well as 
of other unidentified proteins likely related to chromaffin granules. 
punctate  labeling  was  found that  was  more prominent  in 
differentiated cells, concentrated in the Golgi area,  in neu- 
rites,  and  in varicosities.  Similar results  were obtained in 
Bt2cAMP-treated  cells (not shown). 
JH-DA Release 
Spontaneous  Release.  The rate of spontaneous release of 
3H-DA was measured both in control cells and in cells dif- 
ferentiated with either BhcAMP or BrdU. As shown in Fig. 
7 during the first 5 min of incubation a  significant release 
('~20%) was detected followed by a slow decline during the 
next 60 rain.  The rate of spontaneous release is very similar 
in the three types of cells. 
Secretagogue-induced Release.  In Table II the results of 
secretagogue-induced neurotransmitter release experiments 
on control and differentiated cells are reported.  Regardless 
of the agent tested (Table  II, Control column) nondifferen- 
tiated  IMR-32  cells  do  not  release  3H-DA.  On  the  other 
hand,  BrdU-differentiated cells  are  able to  release  3H-DA 
either in response to ionomycin or to c~-LTx (Table II, BrdU 
column).  TPA alone  induces only a  slight 3H-DA  release 
which is however additive with the ionomycin effect. In con- 
trast, Bt2cAMP-differentiated  IMR-32 cells were not able to 
release 3H-DA in response to either the calcium ionophore 
ionomycin, or to TPA (Table  II, Bt2cAMP column).  Only 
c~-LTx was  able  to  induce  a  significant release  of 3H-DA 
from such cells, although at a reduced level when compared 
to BrdU-differentiated cells.  Since the level  of spontaneous 
release  is equivalent in control and differentiated cells,  we 
can thus exclude the possibility that the different ability to re- 
lease 3H-DA in response to secretagogues (see results  above) 
Figure 3. Transmission electron microscopy of control and differen- 
tiated IRM-32 cells. Control cells (a) are almost devoid of secretory 
granules. In contrast Bt2cAMP-  (b) and BrdU- (c) treated cells con- 
tain many secretory organelles with a typical dense core, which are 
particularly concentrated in the neurites. Bar, 1 /~m. 
Sher et al. Secretory Ability in Differentiating Neuroblastoma  2295 Figure 5. Immunolocalization  of Cgs/Sgs in control and differentiated IMR-32 cells. In a and b two fields of control IMR-32 cultures are 
shown, with no neurites and very few labeled granules. In c and d two cells from BrdU-differentiated culture are shown: a typical punctate 
fluorescence is evident in the Golgi area (arrows) and in the neurites (arrowheads). (e) One field from BrdU-differentiated cells showing 
the ramification pattern of the heavy-labeled neurites. Note the dotted appearance of the immunostained neurites making contact with a 
neighbor cell (arrowhead). Arrow, Golgi area. Bars, 25/xm. 
could be due to a modification of the basal rate of release in- 
duced by the differentiating drugs, o~-LTx in Bt2cAMP- and 
BrdU-treated IMR-32 cells, as in other systems (Meldolesi 
et al., 1986), was able to induce neurotransmitter release even 
in the absence of extracellular calcium and at levels  only 
slightly lower than  those observed in  the  presence  of ex- 
tracellular calcium (Table  III). 
Age-dependent Effects of Secretagogues.  The difference 
in response to secretagogues between Bt2cAMP- and BrdU- 
differentiated cells might be due to the fact that the two drugs 
induce different pathways of differentiation or to the fact that 
there  is  a  lower level  of morphological maturation of the 
Bt2cAMP-treated  cells. In fact, from a morphological point 
of view,  Bt2cAMP-induced cell differentiation is  similar to 
the  early stages of BrdU-induced differentiation.  Further- 
more cell shape is known to influence dopamine processing 
at least  in  PC12 cells  (Bethea et al.,  1987).  We therefore 
tested the release capacity of cells differentiated for only five 
d. In Table IV the results of such experiments are reported. 
"Younger" cells release quantitatively less 3H-DA than "old- 
er" cells in response to the various secretagogues. However, 
a  significant difference  still  exists  between  Bt2cAMP-  and 
BrdU-treated cells in terms of the ratio between c~-LTx and 
ionomycin-induced release,  indicating  that Bt2cAMP-treated 
cells do not represent, in this respect, an "intermediate" step 
in BrdU-induced cell differentiation. 
The Journal of Cell Biology, Volume  108, 1989  2296 Figure 6.  Detection of synaptophysin in control and differentiated IMR-32 cells.  (a) Western blotting with afffinity-purified  polyclonal 
anti-synaptophysin antibodies. Equal amounts of proteins from control (lane 1 ) and differentiated (lane 2) IMR-32 cell homogenates were 
separated by SDS-PAGE, blotted,  and immunostained as described in Materials and Methods.  Proteins from bovine posterior pituitary, 
known to contain synaptophysin (Navone et al.,  1988),  were loaded in lane 3 as a positive control. A stronger labeling (,'~100% increase) 
of the doublet corresponding to the differently glycosylated forms of synaptophysin (syn), is evident in differentiated versus control cells. 
(b, c, and d) Immunofluorescence of synaptophysin in control (b) and differentiated (c and d) IMR-32 cells. It can be seen that particularly 
in differentiated cells there is dotted labeling scattered in the cytoplasm, in the Golgi area, and in the neurites. Labeled neurite varicosities 
are shown in d. Arrow, Golgi area. Bars, 25/xm. 
Secretagogue-induced Modification of  lntracellular 
Calcium Levels 
Both  ionomycin  and  c~-LTx  promote an  increase  in  [Ca2÷]~ 
in a calcium-containing  medium (Sher et al.,  1988b).  Trac- 
ings from experiments performed with the fluorimetric Ca  2+ 
probe Quin2  (Fig.  8)  support the view that c~-LTx-induced 
3H-DA  release  is  Ca  2+  independent.  In  Fig.  8  a  a  typical 
tracing  obtained  when  u-LTx is added  to BhcAMP-treated 
cells  in a  calcium containing  KRH medium  (see Materials 
and  Methods)  is shown:  after 30-40  s,  [Ca2+]~ increases  to 
very high levels (•1  ttM) and decreases only after the addi- 
tion of 1 mM EGTA. When EGTA is added before the toxin 
(Fig.  8  c),  no increase  in  [Ca2÷]~ is caused by ot-LTx,  indi- 
cating that it does not induce calcium redistribution from in- 
ternal stores. Identical results were obtained in BrdU-treated 
ceils  (not shown). 
Since in the same experimental conditions  (i.e.,  calcium- 
free medium plus  EGTA),  c~-LTx is able to induce  release 
from both  Bt2cAMP-  and  BrdU-treated  cells,  we can  con- 
clude that in both types of cells this release is not caused by 
calcium influx,  nor by calcium redistribution,  but is medi- 
ated by some other unknown  signal(s). 
The effects of ionomycin on calcium movements were also 
compared.  In a  calcium-containing  medium,  ionomycin in- 
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Figure 7. Rate of spontaneous release of 3H-DA from IMR-32 cells. 
Data are expressed as percent of radioactivity remaining in the cells 
with  respect  to  their  own control.  After  loading  the  cells  with 
3H-DA (0.8 #M, 60 min at 37°C) the cells were washed and left at 
37°C for the  indicated additional  time;  then the cells  were cen- 
trifuged and the pellet radioactivity counted,  e, control cells; o, 
Bt2cAMP-treated cells; A, BrdU-treated cells. Each data point rep- 
resents the average of triplicate determinations. 
duces a great increase in [Ca2+], although lower than a-LTx 
(Fig. 8 b). Ionomycin induces a small and transient increase 
in [Ca2+]~, even in the presence of EGTA (Fig. 8 d), proba- 
bly through the release of calcium from internal stores. The 
subsequent addition to the medium of an excess of calcium 
induces a  steady increase in [Ca2+],  most probably due to 
calcium influx; in the same experimental conditions ionomy- 
cin was not able to induce secretion from BhcAMP-treated 
cells. TPA did not increase [Ca2+]i either in the presence or 
in the absence of calcium in the medium (not shown). 
Discussion 
In the present work we have shown that a human neuroblas- 
toma cell  line,  which  synthesizes  dopamine (Gotti  et al., 
1987) and possesses the dopamine uptake mechanism (Rich- 
ards and Sadee,  1986), but which is unable to release it in 
response to secretagogues (Clement± et al.,  1986), acquires, 
during in vitro differentiation, the ability to secrete the neu- 
Table III. Release of JH-DA from Differentiated IMR-32 
Cells in the Presence or in the Absence of Ca  2÷ in the 
Extracellular Medium 
Percent increase of release 
Drugs  BhcAMP  BrdU 
o~-LTx  13  ±  2  .37  ±  4 
ot-LTx  +  EGTA  10  ±  2  31  ±  5 
The toxin was added for 8 min at 37°C. EGTA concentration was I mM. The 
values represent the average  _+  SEM  of four different experiments. 
rotransmitter  in response to stimulation.  Furthermore,  we 
have shown that  such  cells exhibit alternative pathways of 
differentiation, which differ, according to the differentiating 
agent,  in the way they regulate secretory events. 
Storage of SH-DA 
3H-DA autoradiography clearly indicates that BhcAMP- and 
BrdU-differentiated  IMR-32  cells  can  store SH-DA,  while 
control cells cannot. We have previously shown that differen- 
tiated IMR-32 cells synthesize more neurotransmitters than 
control cells (Gotti et al., 1987), and exhibit as well a bright- 
er endogenous amine histofluorescence (Denis-Don±n±,  S., 
and  E.  Sher,  unpublished  results).  Our present autoradio- 
graphic and immunocytochemical results with the anti-DA 
antiserum, together with the increased sensitivity of differen- 
tiated IMR-32 cells to the granule-depleting drug reserpine, 
suggest that differentiated  IMR-32 cells have developed a 
storage apparatus where they accumulate neurotransmitters, 
that could be released upon stimulation through exocytosis. 
Such  results  were  confirmed  by  electron  microscopy 
which  showed that only differentiated cells contain a  large 
number of secretory organelles, and that the great majority 
of these structures belongs to the "dense-core" vesicle type. 
Moreover, we were able to demonstrate, both by immuno- 
chemical and immunocytochemical approaches with an an- 
tiserum rasied against human purified chromaffin granules, 
that  secretory granule  protein  accumulation  is  greatly  in- 
creased in differentiated neuroblastoma cells. The most abun- 
dant proteins  recognized by this antiserum were CgA and 
Table I1. Release of SH-DA from Control and 
Differentiated Cells 
Percent increase of release 
Drugs  Control  BhcAMP  BrdU 
a-LTx  2.0  ±  1  16  +  2  42  +  2 
(2  x  10  -9  M) 
Ionomycin  4.1  +  1.5  2  _+  1  27  ±  3 
(1  x  10  -6  M) 
TPA  3.0  +  1  I  +0.5  6  ±  2 
(0.1  ×  10  -6  M) 
Ionomycin  +  TPA  6.0  ±  2  3  +_  2  33  ±  6 
Ratio ~LTx/  0.5  8.0  1.5 
ionomycin 
The cells were loaded with SH-DA  (0.8/zM) and the amount of release deter- 
mined after 8  rain,  as described in Materials and  Methods.  Values are ex- 
pressed as a percent increase of release over basal  +  SEM and represent the 
average of five to eight different experiments. DMSO alone induced a release 
of 1-3%  in different experiments. 
Table IV. Role of Cultures'Age on Stimulated 
3H-DA Release 
Percent  increase of release 
Bt2cAMP  BrdU 
I  wk  2  wk  I  wk  2  wk 
ot-LTx  13.7  18.7  28.0  41.6 
(2  X  10  -9  M) 
Ionomycin  2.6  3.2  18.1  26.8 
(1  x  10  -6  M) 
TPA  3.5  -  -  - 
(0.1  x  10  -6  M) 
Ionomycin  +  TPA  3.0  2.6  21.3  37.0 
Ratio o~-LTx/ionomycin  5.2  5.8  1.5  1.5 
The drugs were present for 5 or 12 d in I- and 2-wk-old cultures, respectively. 
Values are expressed as a percentage of release over basal level, as described 
in legend of Table 1,  and are representative of at least three different assays. 
The Journal of Cell Biology, Volume  108,  1989  2298 [c,  2"] 
e(Ita  I  '  nM 
! 
egta 
a  b 
egta 
c  d  ! 
egtl  altx  egta  4ono  CaCl2 
!  T  lao_  T  ~  !/ 
Figure 8. Quin2 measurements of [Ca2+]i changes in IMR-32 cells 
exposed to (a) c~-LTx, 2  x  10  -9 M, followed by EGTA 2  x  10  -3 
M; (b) ionomycin, 1 x  104 M followed by EGTA 2  ×  10  -3 M. 
(c) a-LTx, 2 ×  10  -9 M in calcium-free medium; (d) ionomycin in 
calcium-free medium; values shown represent the [Ca2+]~ (in nM) 
calibration  scale. These  particular  traces  were  obtained  from 
Bt2cAMP-treated cells,  but  identical results were obtained from 
control and BrdU-treated cells (not shown). 
CgB/Sgl, i.e., the secretory acidic proteins present in chro- 
maffin granules of adrenal medulla (Winkler et al.,  1986), 
human pheochromocytoma (Schober et al.,  1987), or PC12 
cells (Lee and Huttner, 1983). We have also followed the ex- 
pression, in control and differentiated cells of a single, spe- 
cific marker of the membrane of secretory organelles, i.e., 
synaptophysin whose expression is known to be developmen- 
tally regulated (Knaus et al., 1986). Also in this case we have 
found, by both immunoblotting and  immunofluorescence, 
that differentiated cells express a higher amount of this vesi- 
cle protein. 
There is still debate on the subtypes of secretory vesicles 
that carry this antigen (Navone et al.,  1986;  Lowe et al., 
1988; Obendorf et al.,  1988), but probably more than one 
type of vesicle can carry this protein. 
Our results therefore show that differentiation of IMR-32 
cells considerably affects the expression of storage organ- 
elles as indicated by the presence of stored DA, of "dense 
core" granules, of a protein of the secretory organelle mem- 
brane (synaptophysin), and of secretory proteins (chromo- 
granins/secretogranins)  known  to  be  stored  in  secretory 
granules (Neuman et al.,  1984; Somogyi et al.,  1984; Rosa 
et al.,  1985; Winkler et al.,  1986). 
While a similar in vitro induction of storage properties was 
recently described in a pituitary cell line (Scammel et al., 
1986), this is the first time that such a process is described 
in neuronal cells in culture. 
~H-DA Release 
As a  result of this differentiation-induced storage capacity 
IMR-32 cells acquire the ability to release 3H-DA in a reg- 
ulated  fashion,  i.e.,  in  response to different secretagogue 
stimuli. 
In  BrdU-differentiated cells both  ionomycin (which  in- 
duces a great influx and redistribution of calcium into the 
cells,  activating the Ca2+-dependent  pathway for secretion 
[Augustine et al.,  1987]),  and  ~-LTx (a presynaptic neu- 
rotoxin capable of inducing massive neurotransmitter release 
from all synapses studied until now [Meldolesi et al., 1986]), 
induced a significant release of 3H-DA.  ~-LTx induced 3H- 
DA release also in a calcium-free medium and without mo- 
bilizing calcium from intracellular stores, a behavior similar 
to that described in  PC12 pheochromocytoma cells (Mel- 
dolesi et al.,  1984). Although TPA alone had little effect in 
inducing 3H-DA release from the different types of IMR-32 
cells, it did, however, have an additive effect to that of the 
calcium ionophore. This is at variance with the results ob- 
tained  in  PC12  cells,  where  TPA acts  in  synergism with 
Ca  2+ in inducing 3H-DA release (Pozzan et al.,  1984). 
Ca2+-dependent and Ca2+-independent ~H-DA Release 
A  very interesting finding that deserves discussion  is  the 
peculiar behavior of Bt2cAMP-differentiated  ceils, which re- 
flects important molecular differences from both control and 
BrdU-differentiated cells.  While  we found that Bt2cAMP- 
differentiated cells (just as BrdU-differentiated cells) contain 
more catecholamines than control cells (Gotti et al.,  1987), 
and express a higher ability to store 3H-DA in secretory or- 
ganelles, they do not release 3H-DA in response to the cal- 
cium ionophore ionomycin in the presence or absence of 
TPA, but they do release it in response to ct-LTx, even in a 
calcium-free medium. 
This suggests that some step, distal to calcium influx and 
protein kinase C activation, is not functioning in this partic- 
ular phenotype and that, therefore, this kind of stimulus-se- 
cretion coupling is not efficient. Much evidence is accumu- 
lating that exocytosis in several cell systems can proceed in 
the virtual absence of Ca  2+ in the medium and without acti- 
vation of protein kinases (Barrowman et al.,  1986; Bittner 
et al.,  1986; Vallar et al.,  1987; Neher,  1988). In the same 
systems GTP analogues can trigger exocytosis by activating 
a yet unknown GTP-binding protein. Since the experiments 
were performed by means of considerable manipulation of 
the cell ionic homeostasis their physiological relevance is 
still to be clarified. 
We here demonstrate, for the first time, that an intact cell 
exists, where an alternative pathway of secretion, indepen- 
dent  from  Ca  2+  and  protein  kinase  C,  is  physiologically 
present. 
BtEcAMP-  and  BrdU-differentiated IMR-32  cells  could 
represent different temporal steps of the same developmental 
program or two distinct,  although interconnected, lines of 
differentiation (Gotti et al.,  1987).  Our results on 3H-DA 
release in "younger" BrdU-treated cells support the latter hy- 
pothesis. "Younger" BrdU-treated cells behave more like "old- 
er" BrdU-treated cells than like Bt2cAMP-treated cells,  at 
least as far as stimulus-secretion coupling is concerned. 
In  conclusion these  human  neuronal  cells,  after drug- 
induced in vitro differentiation, acquire the ability to release 
the  neurotransmitter  3H-DA  in  a  regulated  fashion.  This 
process involves the coordinate expression of secretory gran- 
ule components and their assembly in mature secretory or- 
ganelles.  These  findings  suggest  that  this  cellular model 
could be a very interesting tool for studying the control of 
transmitter secretion in human neurons and its modulation 
during neuronal development since it is amenable to manipu- 
lation and molecular dissection. 
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